我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

If you are interested in applying for this study, please:
  • read the study description and study information document
  • review the Visit Planner dates in your location and confirm that you are available for the stated dates.
  • If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
  • If you have already registered with us, answer the pre-screening questions listed below and submit your interest.

We will then contact you to check your suitability.

Study Description

New Zealand Clinical Research is trialling an investigational medication that is being developed for the treatment of acute (short-term) and chronic (long-term) pain.

Almost 1 in 6 people in New Zealand have reported that they experience chronic pain which affects their quality of life. This medication is being investigated for the first time to evaluate how safe and well tolerated it is, in healthy people.

LTG-305 is designed to work by blocking pathways in the brain that are associated with the sensing of pain.

This is an investigational drug because it has not been approved by MedSafe or other drug regulatory authorities.

This study (2024 FULL 20202) is being funded by Latigo Biotherapeutics, Inc and has been approved by the Health and Disability Ethics Committee.

Requirements

Healthy Males only

  • Aged between 18 – 55 years
  • BMI (Body Mass Index) between 18 – 32 kg/m2
  • Non-smokers/vapers allowed
  • Not currently taking any regular prescription medications
  • Cold Pressor Test (CPT) – Not have any conditions which affect your skin on your arms and hands, or how you feel pain

What is Involved?

Study visits:
2 x 5-night stays (for a total of 10-nights) + 1 follow-up phone call

Reimbursement:
Up to $6,600 (before tax)

Important Documents

Important documents to download and read

Pre-screening Form

Petal Part C

Pre screening form for PETAL PART C study

Personal details

Please provide your name, email and phone number so we can contact you

Medical questions

This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using 2 forms of contraception?
Do you have any history of medical conditions relating to:
Have you donated blood or plasma in the last few months?
Do you have any history of allergies, asthma, hay fever, food allergies etc that you are aware of?
Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 14 days?
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up, or you may only be offered a position as a back-up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
Pre-screening form policy(Required)
I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.